See Articles, pages xx-xx
To read this article in full you will need to make a payment
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 2020;17(9):557-588.
The tumour microenvironment and immune milieu of cholangiocarcinoma.
Liver Int. 2019; 39: 63-78
Single-cell genomics and spatial transcriptomics: discovery of novel cell states and cellular interactions in liver physiology and disease biology.
J Hepatol. 2020;
Single cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.
J Hepatol. 2020;
Emerging roles of SPINK1 in cancer.
Clin Chem. 2016; 62: 449-457
Targeting natural killer cells and natural killer T cells in cancer.
Nat Rev Immunol. 2012; 12: 239-252
Targeting PVR (CD155) and its receptors in anti-tumor therapy.
Cell Mol Immunol. 2019; 16: 40-52
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Gastroenterology. 2012; 142: 1021-1031.e15
Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma.
Molecular profiling of stroma identifies Osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.
Hepatology. 2013; 58: 1992-2000
Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure.
Clin Proteomics. 2019; 16: 37
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
Hepatology. 2013; 58: 1042-1053
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
J Hepatol. 2019; 70: 700-709
Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles.
Hepatology. 2015; 61: 1041-1055
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.
Hepatology. 2013; 58: 2001-2011
Neoplastic transformation of the peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis.
Hepatology. 2019; 69: 622-638
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
Cancer Res. 2013; 73: 897-907
Photothermal depletion of cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma.
ACS Nano. 2020; 14: 5738-5753
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Cancer Cell. 2014; 25: 735-747
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
Cancer Cell. 2014; 25: 719-734
Published online: September 05, 2020
In Press Journal Pre-Proof
Author names in bold designate shared co-first authorship
© 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Access this article on ScienceDirect